Sihuan Pharmaceutical Valuation
| SHPHF Stock | USD 0.10 0.00 0.00% |
Sihuan Pharmaceutical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Sihuan Pharmaceutical from inspecting the company fundamentals such as Return On Equity of -0.0487, insignificant operating margin, and Shares Outstanding of 9.33 B as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sihuan Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of Sihuan Pharmaceutical is based on 3 months time horizon. Increasing Sihuan Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sihuan pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Sihuan Pharmaceutical Holdings. Since Sihuan Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sihuan Pink Sheet. However, Sihuan Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.0882 | Hype 0.1 | Naive 0.1 |
The real value of Sihuan Pink Sheet, also known as its intrinsic value, is the underlying worth of Sihuan Pharmaceutical Company, which is reflected in its stock price. It is based on Sihuan Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sihuan Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sihuan Pharmaceutical Holdings helps investors to forecast how Sihuan pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sihuan Pharmaceutical more accurately as focusing exclusively on Sihuan Pharmaceutical's fundamentals will not take into account other important factors: Sihuan Pharmaceutical Total Value Analysis
Sihuan Pharmaceutical Holdings is at this time forecasted to have takeover price of 506.36 M with market capitalization of 1.2 B, debt of 844.75 M, and cash on hands of 5.25 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sihuan Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
506.36 M | 1.2 B | 844.75 M | 5.25 B |
Sihuan Pharmaceutical Investor Information
About 55.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sihuan Pharmaceutical last dividend was issued on the 4th of October 2022. The entity had 2:1 split on the 5th of June 2014. Sihuan Pharmaceutical Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Sihuan Pharmaceutical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Sihuan implies not a very effective usage of assets in July.Sihuan Pharmaceutical Ownership Allocation
Sihuan Pharmaceutical shows a total of 9.33 Billion outstanding shares. Sihuan Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sihuan Pharmaceutical Profitability Analysis
The company reported the revenue of 3.29 B. Net Income was 416.51 M with profit before overhead, payroll, taxes, and interest of 2.45 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sihuan Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sihuan Pharmaceutical and how it compares across the competition.
About Sihuan Pharmaceutical Valuation
The pink sheet valuation mechanism determines Sihuan Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sihuan Pharmaceutical. We calculate exposure to Sihuan Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sihuan Pharmaceutical's related companies.Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the Peoples Republic of China. The company was founded in 2001 and is based in Wanchai, Hong Kong. Sihuan Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3896 people.
8 Steps to conduct Sihuan Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sihuan Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sihuan Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sihuan Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sihuan Pharmaceutical's revenue streams: Identify Sihuan Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sihuan Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sihuan Pharmaceutical's growth potential: Evaluate Sihuan Pharmaceutical's management, business model, and growth potential.
- Determine Sihuan Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sihuan Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Sihuan Pharmaceutical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Sihuan Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9.3 B | |
| Quarterly Earnings Growth Y O Y | -0.933 | |
| Retained Earnings | 4.9 B |
Complementary Tools for Sihuan Pink Sheet analysis
When running Sihuan Pharmaceutical's price analysis, check to measure Sihuan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sihuan Pharmaceutical is operating at the current time. Most of Sihuan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sihuan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sihuan Pharmaceutical's price. Additionally, you may evaluate how the addition of Sihuan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |